Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer

Vincenzo Ronca, Matteo Barabino, Roberto Santambrogio, Enrico Opocher, James Hodson, Emanuela Bertolini, Simone Birocchi, Gaetano Piccolo, PierMaria Battezzati, Marco Cattaneo, Gian Marco Podda – 29 October 2021 – In patients with cirrhosis with severe thrombocytopenia (platelet count [PC] <50 × 109/L) and undergoing invasive procedures, it is common clinical practice to increase the PC with platelet transfusions or thrombopoietin receptor agonists to reduce the risk of major periprocedural bleeding.

Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma

Christine L. Zimmer, Iva Filipovic, Martin Cornillet, Colm J. O’Rourke, Lena Berglin, Hannes Jansson, Dan Sun, Otto Strauss, Laura Hertwig, Helene Johansson, Erik Seth, Ernesto Sparrelid, Joana Dias, Hans Glaumann, Espen Melum, Ewa C. Ellis, Johan K. Sandberg, Jesper B. Andersen, Annika Bergquist, Niklas K. Björkström – 29 October 2021

Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies

Philipp Königshofer, Benedikt Silvester Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, Oleksandr Petrenko, Katharina Wöran, Merima Herac, Judith Stift, Katharina Lampichler, Gerald Timelthaler, David Bauer, Lukas Hartl, Bernhard Robl, Maria Sibila, Bruno K. Podesser, Georg Oberhuber, Philipp Schwabl, Mattias Mandorfer, Michael Trauner, Thomas Reiberger – 29 October 2021

A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation

Cheng Han Ng, Darren Jun Hao Tan, Xiong Chang Lim, Jie Ning Yong, Nicholas Syn, Gwyneth Shook Ting Soon, Daniel Q. Huang, Jieling Xiao, Grace En Hui Lim, Wen Hui Lim, Eunice Xiang Xuan Tan, Yock Young Dan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 28 October 2021 – Early detection of liver graft fibrosis is crucial for risk stratification to identify patients for liver biopsy and timely treatment. However, diagnostic accuracy of noninvasive tests (NITs) remains unclear.

Subscribe to